Come up with a name for your new list and we'll add to it:
BIND Therapeutics raised a round of funding on October 09, 2007. Investors include
National Cancer Institute.
BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its medicinal nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal nano…